Literature DB >> 16695962

Differences in Cyclic AMP Changes after Stimulation by Prostaglandins and Isoproterenol in Lymphocyte Subpopulations.

M A Bach1.   

Abstract

Various lymphocyte populations have been studied for their content in cyclic adenosine 3',5'-monophosphate (cAMP) before and after stimulation by isoproterenol and prostaglandin E(1) (PGE(1)). Basal cAMP levels vary among lymphocytes according to their origin: peripheral blood lymphocytes show high cAMP level while spleen and lymph node cells and thymocytes show lower levels. Thymocytes are extremely sensitive to the stimulating effects of isoproterenol and PGE(1), much more than spleen and lymph node or peripheral blood cells. Corticoresistant thymocytes are less sensitive to isoproterenol stimulation than normal thymocytes, but are significantly more sensitive than peripheral thymus-derived (T)-cells. Studies using bone-marrow-derived (B) or T cell depletion with anti-immunoglobulin-coated columns and antitheta serum (AthetaS) indicate that lymph node B cells synthesize more cAMP in the presence of isoproterenol than T cells. However, this difference between T and B cells has not been found in spleen cells.

Entities:  

Year:  1975        PMID: 16695962      PMCID: PMC301854          DOI: 10.1172/JCI108008

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  26 in total

1.  Influence of cyclic AMP on early events of the immune induction.

Authors:  R Bosing-Schneider; M Kolb
Journal:  Nature       Date:  1973-07-27       Impact factor: 49.962

2.  The effect of cyclic AMP and related compounds on human lymphocyte transformation (HLT) stimulated by phytohemagglutinin (PHA).

Authors:  P G Rigby; W L Ryan
Journal:  Rev Eur Etud Clin Biol       Date:  1970 Aug-Sep

3.  Effect of cyclic 3',5'-adenosine monophosphate and theophylline on lymphocyte transformation.

Authors:  R Hirschhorn; J Grossman; G Weissmann
Journal:  Proc Soc Exp Biol Med       Date:  1970-04

4.  Cyclic adenosine 3',5'-monophosphate in human lymphocytes. Alterations after phytohemagglutinin stimulation.

Authors:  J W Smith; A L Steiner; W M Newberry; C W Parker
Journal:  J Clin Invest       Date:  1971-02       Impact factor: 14.808

5.  Enhanced effects of prostaglandin E1 and dibutyryl cyclic AMP upon human lymphocytes in the presence of cortisol.

Authors:  J Mendelsohn; M M Multer; R F Boone
Journal:  J Clin Invest       Date:  1973-09       Impact factor: 14.808

6.  Separation of specific antibody-forming mouse cells by their adherence to insolubilized endogenous hormones.

Authors:  K L Melmon; Y Weinstein; G M Shearer; H R Bourne; S Bauminger
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

7.  A protein binding assay for adenosine 3':5'-cyclic monophosphate.

Authors:  A G Gilman
Journal:  Proc Natl Acad Sci U S A       Date:  1970-09       Impact factor: 11.205

8.  In vitro induction of specific unresponsiveness of immunologically reactive, normal bone marrow cells.

Authors:  S K Singhal; H Wigzell
Journal:  J Exp Med       Date:  1970-01-01       Impact factor: 14.307

9.  Hormone-like activity of a thymus humoral factor on the induction of immune competence in lymphoid cells.

Authors:  A I Kook; N Trainin
Journal:  J Exp Med       Date:  1974-01-01       Impact factor: 14.307

10.  The modulating influence of cyclic nucleotides upon lymphocyte-mediated cytotoxicity.

Authors:  T B Strom; C B Carpenter; M R Garovoy; K F Austen; J P Merrill; M Kaliner
Journal:  J Exp Med       Date:  1973-08-01       Impact factor: 14.307

View more
  23 in total

1.  The differential effect of cyclic AMP on lymphocyte stimulation by T- or B-cell mitogens.

Authors:  T L Vischer
Journal:  Immunology       Date:  1976-05       Impact factor: 7.397

2.  Cyclic AMP production during adjuvant-induced arthritis in rats [proceedings].

Authors:  M J Adolfs; I L Bonta; M J Parnham
Journal:  Br J Pharmacol       Date:  1977-03       Impact factor: 8.739

3.  Pharmacological control of the hormonally modulated immune response. II. Blockade of antibody production by a combination of drugs acting on neuroendocrine functions. Its prevention by gonadotropins and corticotrophin.

Authors:  W Pierpaoli; G J Maestroni
Journal:  Immunology       Date:  1978-03       Impact factor: 7.397

Review 4.  Autonomic regulation of T-lymphocytes: Implications in cardiovascular disease.

Authors:  Safwan K Elkhatib; Adam J Case
Journal:  Pharmacol Res       Date:  2019-06-06       Impact factor: 7.658

5.  Pharmacologic effects of autacoids on subsets of T cells. Regulation of expression/function of histamine-2 receptors by a subset of suppressor cells.

Authors:  M M Khan; P Sansoni; E G Engleman; K L Melmon
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

6.  Clinical and laboratory effects of nifedipine in Raynaud's phenomenon.

Authors:  S J Hawkins; C M Black; N D Hall; A McGregor; E F Ring; P J Maddison
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

7.  Theophylline modulation of E-rosette formation: an indicator of T-cell maturation.

Authors:  S Limatibul; A Shore; H M Dosch; E W Gelfand
Journal:  Clin Exp Immunol       Date:  1978-09       Impact factor: 4.330

8.  Prostaglandin E1 infusions for vascular insufficiency in progressive systemic sclerosis.

Authors:  M F Martin; P M Dowd; E F Ring; E D Cooke; P A Dieppe; J D Kirby
Journal:  Ann Rheum Dis       Date:  1981-08       Impact factor: 19.103

9.  Low beta-adrenergic receptor concentration on human thymocytes.

Authors:  R J van de Griend; A Astaldi; P Wijermans; R van Doorn; D Roos
Journal:  Clin Exp Immunol       Date:  1983-01       Impact factor: 4.330

10.  Inhibition of lymphocyte activation by catecholamines: evidence for a non-classical mechanism of catecholamine action.

Authors:  J M Cook-Mills; R L Cohen; R L Perlman; D A Chambers
Journal:  Immunology       Date:  1995-08       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.